[Hemodilution therapy with neuron metabolism specific therapy in ischemic stroke--encouraging results of a comparative study].
Treating ischemic stroke we could compare a (control-)group of 318 patients under up to date hemodilution therapy to a group of 100 patients receiving exactly the same treating scheme but including an add-on administering of Cerebrolysin. It proved a statistically validated better outcome within the Cerebrolysin add-on treated group evaluated by the Barolin-Neuro-Rehabilitation Scale. 1) More effect on social and occupational parameters than on motor functions, but also including some of those. 2) Cerebrolysin accelerates recovery and therewith offers better starting points for rehabilitation. As stroke is one of the main social-medical neuro-rehabilitation and gerontological problems of our days these results should be recognized in a general therapeutical use.
Koppi
S
S
Aus der Neurologischen Abteilung, Ludwig-Boltzmann-Institut für Neuro-Rehabilitation und -Prophylaxe.
Barolin
G S
GS
D000203:Activities of Daily Living / Q000145:classification; D000596:Amino Acids / Q000008:administration & dosage* / Q000009:adverse effects; D002544:Cerebral Infarction / Q000175:diagnosis / Q000534:rehabilitation*; D004185:Disability Evaluation; D004678:Encephalomalacia / Q000175:diagnosis / Q000534:rehabilitation; D004734:Energy Metabolism / Q000187:drug effects / Q000502:physiology; D006438:Hemodilution / Q000379:methods*; D006801:Humans; D009460:Neurologic Examination / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D009483:Neuropsychological Tests; D012050:Rehabilitation, Vocational; D016896:Treatment Outcome
D000596:Amino Acids; C006952:cerebrolysin